LAMEA Cardiovascular Digital Solutions Market

LAMEA Cardiovascular Digital Solutions Market Size, Share & Industry Trends Analysis Report By Service Type, By End-use, By Deployment (Cloud-Based and On-premise), By Components (Devices and Software), By Country and Growth Forecast, 2022 - 2028

Report Id: KBV-13739 Publication Date: February-2023 Number of Pages: 102
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support

Market Report Description

The Latin America, Middle East and Africa Cardiovascular Digital Solutions Market would witness market growth of 11.1% CAGR during the forecast period (2022-2028).

One of the biggest issues facing healthcare professionals is providing patients with CVDs with the best practice care. Management of CVDs must be frequent, ongoing, and seamless. In order to help patients, their families, and communities manage and improve their health, digital technologies will continue to be implemented with a focus on these diseases. This will be done by raising standards of care, expanding access to equity, boosting efficiency, and encouraging better patient self-management.

Digital solutions have been developed to treat, manage, and prevent a condition. It represents a digital health solution that delivers medicinal interventions directly to patients. Such solutions typically use software or technologies that are evidence-based and clinically proven to collect real-time patient information and offer a better therapeutic response. Digital solutions have drawn a lot of interest from both investors and industry stakeholders because of the continuous digitization efforts and modernization of the healthcare sector. Additionally, government agencies have taken active steps to establish regulations, publish laws, and implement legislation in the field of digital therapies.

In the Latin American region, the Argentine government has additionally established an interoperability center where all parties (public and commercial) can collaborate to produce synergies that ought to result in better patient results. In Brazil, the COVID-19 outbreak catalyzed the creation of digital health policies. The establishment of genuine governing entities (like the National Health Data Network - Rede Nacional de Dados em Sade) in preparation for implementing a significant data-driven healthcare plan incorporating technology has been noted as one of the main projects. Brazilian experts believe that this disruption has the potential to significantly alter how healthcare is organized and delivered in the region. Hence, the significant initiatives taking place in the region to promote the delivery of healthcare are the major factors accelerating the expansion of the cardiovascular digital solution market in the region.

The Brazil market dominated the LAMEA Cardiovascular Digital Solutions Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $2,721.9 Million by 2028. The Argentina market is experiencing a CAGR of 11.7% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 10.8% during (2022 - 2028).

Based on Service Type, the market is segmented into Unobtrusive Testing, CVD Health Informatics, Cardiac Rehab Programs and Others. Based on End-use, the market is segmented into Hospitals & Clinics, Ambulatory Care Centers and Others. Based on Deployment, the market is segmented into Cloud-Based and On-premise. Based on Components, the market is segmented into Devices and Software. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

Free Valuable Insights: The Worldwide Cardiovascular Digital Solutions Market is Projected to reach USD 128.1 Billion by 2028, at a CAGR of 4.8%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Apple, Inc., General Electric Company, Koninklijke Philips N.V., Verily Life Sciences LLC (Alphabet, Inc.), iRhythm Technologies, Inc., Bardy Diagnostics, Inc. (Hill-Rom Holdings Inc) (Baxter International Inc.), eviCore Healthcare (Express Scripts Holding Company) (Cigna Corporation), AliveCor, Inc., Cardiotrack, and HeartFlow, Inc.

Scope of the Study

Market Segments Covered in the Report:

By Service Type

  • Unobtrusive Testing
  • CVD Health Informatics
  • Cardiac Rehab Programs
  • Others

By End-use

  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Others

By Deployment

  • Cloud-Based
  • On-premise

By Components

  • Devices
  • Software

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Apple, Inc.
  • General Electric Company
  • Koninklijke Philips N.V.
  • Verily Life Sciences LLC (Alphabet, Inc.)
  • iRhythm Technologies, Inc.
  • Bardy Diagnostics, Inc. (Hill-Rom Holdings Inc) (Baxter International Inc.)
  • eviCore Healthcare (Express Scripts Holding Company) (Cigna Corporation)
  • AliveCor, Inc.
  • Cardiotrack
  • HeartFlow, Inc.
Need a report that reflects how COVID-19 has impacted this market and its growth? Download Free Sample Now


Call: +1(646) 600-5072


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo